AbbVie North Chicago plant has second fire

A fireman holding a firehose that is open and expelling water

An AbbVie ($ABBV) manufacturing facility in North Chicago had a fire in a laboratory this week. The origin of the blaze was believed to be electrical but AbbVie is investigating since it is the second fire at the plant in two months.

The firefighters were called in Tuesday night after a fire started in a laboratory and electronics storage room of the contract manufacturing plant, according to the Chicago Tribune. The blaze was contained to the room.

No one was hurt, Fire Chief Dell Urban told the newspaper. “The fire was held in check by the sprinkler system. Everyone had been evacuated and there were no injuries," Urban was quoted as saying.


Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

Urban said there had been another fire recently, also contained by the sprinkler system. According to a couple of online reports, there was a fire at the plant April 4.

An AbbVie spokeswoman in an email would only confirm there was a fire and that there were no injuries and that production at the facility was unaffected.

While uncommon, fires do happen at pharma manufacturing facilities. Amgen ($AMGN) had two explosions and fires that injured people 9 months apart in May 2013 and January 2014 at Amgen's South San Francisco lab facility. It received a citation from the California OSHA.

- read the Chicago Tribune story

Related Articles:
Amgen facility has its second explosion in 9 months
Worker hurt in 'flash fire' at Amgen facility


Suggested Articles

Higher operating costs were behind a 17% slide in pretax profits last year at Allergan’s Mayo, Ireland, facility that produces Botox.

After a global scare over Zantac contamination, generic metformin could be next in line as regulators test for possible carcinogen contamination.

PCI Pharma Services debuts expansion of its plant in Rockford, Illinois.